These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17299914)

  • 21. An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia.
    Shankey TV; Forman M; Scibelli P; Cobb J; Smith CM; Mills R; Holdaway K; Bernal-Hoyos E; Van Der Heiden M; Popma J; Keeney M
    Cytometry B Clin Cytom; 2006 Jul; 70(4):259-69. PubMed ID: 16906581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia using experimentally optimized isotypic control antibodies.
    Preobrazhensky SN; Szankasi P; Bahler DW
    Cytometry B Clin Cytom; 2012 Mar; 82(2):78-84. PubMed ID: 22031469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal.
    Marquez ME; Deglesne PA; Suarez G; Romano E
    Int J Lab Hematol; 2011 Apr; 33(2):194-200. PubMed ID: 20942870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.
    Trojani A; Montillo M; Nichelatti M; Tedeschi A; Colombo C; Veronese S; Mura MA; Ricci F; Scarpati B; Colosimo A; Lodola M; Morra E
    Cancer Biomark; 2010; 6(1):1-9. PubMed ID: 20164537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
    Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
    Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
    Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
    Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.
    Carreras J; Villamor N; Colomo L; Moreno C; Ramón y Cajal S; Crespo M; Tort F; Bosch F; López-Guillermo A; Colomer D; Montserrat E; Campo E
    J Pathol; 2005 Mar; 205(4):507-13. PubMed ID: 15685592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    Cytometry B Clin Cytom; 2006 Jul; 70(4):209-13. PubMed ID: 16906583
    [No Abstract]   [Full Text] [Related]  

  • 33. New prognostic markers in chronic lymphocytic leukemia.
    Moreno C; Montserrat E
    Blood Rev; 2008 Jul; 22(4):211-9. PubMed ID: 18448218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.
    Orchard JA; Ibbotson RE; Davis Z; Wiestner A; Rosenwald A; Thomas PW; Hamblin TJ; Staudt LM; Oscier DG
    Lancet; 2004 Jan; 363(9403):105-11. PubMed ID: 14726163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied.
    Wilhelm C; Neubauer A; Brendel C
    Cytometry B Clin Cytom; 2006 Jul; 70(4):242-50. PubMed ID: 16906574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
    Zanotti R; Frattini F; Ghia P; Visco C; Zamò A; Perbellini O; Stella S; Facco M; Giaretta I; Chilosi M; Pizzolo G; Ambrosetti A
    Am J Hematol; 2010 Jul; 85(7):494-8. PubMed ID: 20575031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL/SLL.
    Sup SJ; Domiati-Saad R; Kelley TW; Steinle R; Zhao X; Hsi ED
    Am J Clin Pathol; 2004 Oct; 122(4):582-7. PubMed ID: 15487457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
    Marti G; Orfao A; Goolsby C
    Cytometry B Clin Cytom; 2006 Jul; 70(4):197-200. PubMed ID: 16906575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.